DECISION

BioPharma Co. builds medicines for rare and ultra-rare diseases. In just a few years it had remade itself: a completely new C-suite, a new headquarters, and a workforce that had grown by 200%. On top of all that reinvention, the CEO made a public commitment. Innovation would be one of four core values, and the company would build a world-class innovation capability to back it.

It was the right call, and it was made out loud, in front of the whole company. Customer-centricity, the first of the values, had already been brought to life the year before. Innovation was next.

REASONABLE RESISTANCE

But announcing a value and building a capability are two very different things. The organization was already stretched thin by the reinvention, and no one had a shared way to actually innovate. So the value risked doing what values usually do: hanging on the wall while everyone waits for it to mean something.

Every reason to go slow looked responsible. Don’t pile another process onto an exhausted team. Don’t roll anything out until it’s perfect. Wait for a calmer moment. Left alone, “innovation” stays a word in the annual-meeting deck, and the commitment fades.

ACTION

• Designed a simple innovation process that combined Design Thinking and Lean Startup, and folded it into the customer-centricity tools the company already used, so it added a capability without adding weight
• Set clear guiding principles that held for every innovation, whoever was doing it and wherever it happened
• Built an innovation playbook of tools, templates, and worked examples the whole company could follow
• Ran an immersive two-day simulation where executive teams applied every step of the process to a real, pressing business challenge
• Onboarded the company’s new Head of Innovation, setting the stage for years of innovation results

RESULTS

The shift showed up immediately, and it stuck. Right after the simulation:

• Senior leaders started asking questions before jumping to answers, and open questions instead of leading ones
• Teams began running small experiments for real data instead of debating opinions
• Demand for the innovation tools and training outran what the company could supply
• The playbook went out to every employee, and the customer-centricity training was rebuilt to include the innovation process

CAPABILITY KEPT

BioPharma Co. kept a shared, repeatable way to innovate, one that lives in the playbook, the guiding principles, and the customer-centricity work every employee already touches. And it kept an in-house Head of Innovation, at expert level, to carry it forward. The value the CEO announced stopped being a slogan and became something the company actually does.